IQVIA
UnclaimedMarket category: AI Agent Platforms
IQVIA provides healthcare intelligence, clinical research services, commercial insights, and technology to life sciences and healthcare organizations.
Overview
IQVIA provides clinical research services, commercial insights, healthcare intelligence, data, analytics, technology, and expertise to life sciences and healthcare organizations. It supports research and development, evidence generation, commercialization, and healthcare decision-making, with a focus on responsible AI, privacy, regulatory compliance, and improving patient outcomes.
Mission statement
To accelerate the development and commercialization of innovative medical treatments and help improve patient outcomes and population health worldwide.
One of 4 AI agents in Contract Research OrganizationsOne of 89 AI agents in AI Agent Platforms
What we offer
IQVIA Life Science Models
Simulate patient, clinical trial and market outcomes to test decisions, choose stronger options and avoid costly rework.
iqvia.com →Predictive Clinical Development
Identify development risks earlier, prevent delays and make faster decisions to accelerate clinical development planning and delivery.
iqvia.com →IQVIA.ai
IQVIA.ai helps life sciences organizations streamline workflows, accelerate research and analysis, and make more confident, timely decisions.
iqvia.com →IQVIA Field Force Agent
Helps life sciences field teams plan and deliver higher-impact, compliant HCP engagements with real-time insights and curated healthcare data.
iqvia.com →IQVIA Global Market Insights Agent
Connects global market intelligence to help customers understand market shifts, refine launch strategies and identify emerging opportunities.
iqvia.com →IQVIA Commercial Agentic AI
Helps commercial teams improve precision, speed and business impact across workflows and customer journey activities.
iqvia.com →IQVIA Literature AI Platform
Accelerates scientific literature reviews while reducing screening effort and producing rigorous, traceable outputs.
iqvia.com →IQVIA Privacy Analytics Platform
Enables health data use while helping protect individual privacy, including through deployment within England's NHS Federated Data Platform.
iqvia.com →IQVIA SmartSolve RIM
Supports regulatory compliance and global approvals to help enable timely access to healthcare products.
iqvia.com →IQVIA IRT Supply Automation Value Engine (SAVE)
Optimizes clinical trial medicine supply to sites with real-time analytics and automation, helping reduce deliveries and site stockouts.
iqvia.com →AI-enabled clinical decision support tool for type 1 diabetes
Helps identify patients who may have misdiagnosed or misclassified type 1 diabetes while reducing screening burden.
iqvia.com →IQVIA Emerging Biopharma Commercial Solutions
Helps emerging biopharma organizations advance commercialization, improve market access and stakeholder engagement, and maximize asset value from prioritization through growth.
iqvia.com →Research & Development Solutions
Optimize clinical trials, reduce risk and support faster delivery of life-changing therapies with connected data, technology, analytics and R&D services.
iqvia.com →Real World Evidence solutions
Turn real-world information into evidence that supports smarter decisions and helps address clinical, regulatory and commercial questions.
iqvia.com →Commercialization solutions
Improve commercial decisions, strengthen engagement and support brand growth with data, analytics, technology and expertise.
iqvia.com →Safety and regulatory compliance solutions
Streamline safety and compliance work, manage regulatory requirements, and address changing stakeholder demands and cost constraints.
iqvia.com →IQVIA Technologies
Use AI-driven technology and analytics to support greater efficiency and generate business insights without additional capital investment.
iqvia.com →IQVIA Virtual Research
Bring research to patients at home while supporting recruitment, retention, faster study timelines and improved data quality.
iqvia.com →IQVIA Emerging Biopharma Analytics
Turns patient claims data into launch insights to help emerging biopharma companies make faster pre-launch decisions and reduce costs.
iqvia.com →Market segments
Market size by segment
Growth potential (CAGR)
Clinical development
End-to-end clinical trial execution and data management across early‑phase through Phase II–IV, including decentralized/hybrid trials, bioanalytical services, pharmacovigilance, and CDMS implementation to accelerate timelines and improve data quality.
Products: Research & Development Solutions, Predictive Clinical Development, IQVIA Virtual Research, IQVIA IRT Supply Automation Value Engine (SAVE), IQVIA Life Science Models, IQVIA.ai
Life sciences commercialization
Data, analytics and services that help life sciences companies plan product launches, assess markets, establish pricing and access strategies, and improve field execution and healthcare professional engagement.
Products: Commercialization solutions, IQVIA Commercial Agentic AI, IQVIA Emerging Biopharma Analytics, IQVIA Emerging Biopharma Commercial Solutions, IQVIA Explorer, IQVIA Field Force Agent, IQVIA Global Market Insights Agent, IQVIA Life Science Models, IQVIA.ai
Real-world evidence and HEOR
Generation, analysis, and integration of real‑world data and health economics and outcomes research to support regulatory submissions, payer evidence, and value demonstration.
Products: Real World Evidence solutions, IQVIA Literature AI Platform, IQVIA Life Science Models, IQVIA Virtual Research, IQVIA.ai
Pharmacovigilance and regulatory compliance
Services and platforms that help life sciences organizations manage drug safety, regulatory information, approvals, quality requirements and compliance with engagement and transparency obligations.
Products: Safety and regulatory compliance solutions, IQVIA SmartSolve RIM, Real World Evidence solutions
Health data privacy
Platforms that help healthcare and life sciences organizations use sensitive health data for research and analytics while protecting individual privacy.
Products: IQVIA Privacy Analytics Platform
More information about our offering
IQVIA Life Science Models
IQVIA Life Science Models combine longitudinal patient data, biomedical knowledge and predictive AI to simulate outcomes across patients, clinical trials and markets. Life sciences teams can test clinical and commercial decisions before making them, helping them choose stronger options, avoid costly rework and move forward with confidence.
- Test Clinical Study DecisionsExplore study outcomes before making clinical decisions, helping teams choose stronger options and avoid costly rework.
- Simulate Patient OutcomesModel outcomes across patients to evaluate potential scenarios and make more informed decisions.
- Evaluate Market DecisionsSimulate markets to examine commercial choices and select stronger options with greater confidence.
- Combine Data, Knowledge, And AIBring together longitudinal patient data, biomedical knowledge and predictive AI to power simulations across patients, studies and markets.
Predictive Clinical Development
Predictive Clinical Development helps identify and address development risks early to prevent delays and accelerate clinical development planning and delivery. It brings AI and clinical development expertise together with connected data, technology and analytics to optimize trials, support faster decision-making and reduce risk.
- Identify Risks EarlierEarlier visibility into development risks helps teams address potential issues before they lead to delays.
- Accelerate Development DeliveryFaster decision-making and more efficient execution help teams move clinical development planning and delivery forward more quickly.
- Prevent Development DelaysBy helping identify and address risks early, the solution supports actions intended to prevent delays and improve execution.
- Connect Data And AnalyticsConnecting data, technology and analytics supports trial optimization, faster decision-making and reduced development risk.
IQVIA.ai
IQVIA.ai is a unified agentic AI platform purpose-built for life sciences. It combines conversational AI with ready-to-use and configurable intelligent agents, AI-driven workflow automation, advanced analytics and decision support. The platform coordinates tasks and insights across data sources and functions, supporting clinical, commercial and real-world workflows. It is designed to operate securely and in alignment with healthcare regulatory, privacy and quality standards.
Category: AI Agent Platforms
- Scale AI Within Healthcare StandardsIQVIA.ai is designed to operate securely and align with healthcare regulatory, privacy and quality standards, supporting responsible AI adoption at scale.
- Deploy Agents For Life Sciences WorkflowsOrganizations can securely access, deploy and scale IQVIA-powered agents, including ready-to-use and configurable agents designed for life sciences workflows.
- Automate And Streamline Complex OperationsThe platform brings AI-driven automation into operational workflows to help organizations streamline complex work.
- Coordinate Tasks Across Data And FunctionsThe platform coordinates tasks and insights across multiple data sources and functions, bringing intelligence and execution together under one platform.
- Research And Generate Through One ConversationA single conversational experience lets users research, analyze and generate outputs on the platform.
- Analyze Data For Actionable InsightsAdvanced analytics within the unified platform helps organizations analyze data and access insights across their work.
- Support Timely, Confident DecisionsDecision support is integrated into the platform to help organizations make more confident, timely decisions.
- Learn From Operational FeedbackIQVIA.ai is designed to continuously learn from complex operational feedback.
IQVIA Field Force Agent
IQVIA Field Force Agent is an AI-powered assistant that helps life sciences field teams plan and execute high-impact, compliant HCP engagements. It delivers real-time insights using IQVIA’s curated, agent-ready healthcare data, including IQVIA OneKey, to support smarter segmentation, dynamic targeting, and deeper HCP and HCO profiling.
- Plan Compliant HCP EngagementsSupport field teams in planning and carrying out high-impact engagements with healthcare professionals while maintaining compliance.
- Support Field Team WorkGive life sciences field teams AI-powered assistance for planning and executing HCP engagements.
- Guide Engagements With InsightsProvide timely insights that help field teams make informed plans and execute HCP engagements.
- Ground Decisions In Curated DataUse IQVIA’s curated, agent-ready healthcare data, including IQVIA OneKey HCP/HCO reference data, to support segmentation, targeting and profiling.
- Segment HCPs More EffectivelyUse curated healthcare data to support smarter segmentation of healthcare professionals.
- Target HCPs DynamicallySupport dynamic targeting of healthcare professionals as field teams plan and execute engagements.
- Deepen HCP And HCO ProfilesDraw on curated healthcare data to build deeper profiles of HCPs and HCOs for field engagement planning.
IQVIA Global Market Insights Agent
IQVIA Global Market Insights (GMI) Agent uses agentic AI to provide a unified view of the global market landscape and answer multidimensional questions. It analyzes market shifts using real-time HCP sentiment, supports launch strategy optimization with competitive intelligence, identifies trends across sales, promotional channels and physician engagement, and provides forward-looking insights through pipeline analysis and loss-of-protection timelines.
- Unify Global Market InsightsBring market information into a unified view to support multidimensional questions and a broader understanding of the global landscape.
- Track Market ShiftsUse real-time HCP sentiment to analyze market shifts and inform a timely understanding of changing conditions.
- Refine Launch StrategiesApply competitive intelligence to support the optimization of launch strategies.
- Identify Sales TrendsSurface trends across sales to help customers spot patterns relevant to market opportunities.
- Identify Channel TrendsReveal trends across promotional channels to help customers understand market activity.
- Identify Engagement TrendsSurface trends across physician engagement to help customers recognize relevant market patterns.
- Assess Pipeline InsightsUse pipeline analysis to gain forward-looking market insights.
- Review Protection TimelinesUse loss-of-protection timelines as part of a forward-looking view of the market.
IQVIA Explorer
IQVIA Explorer is a commercial decision-support product announced by IQVIA to help life sciences companies make better commercial decisions.
IQVIA Commercial Agentic AI
IQVIA Commercial Agentic AI provides AI agents designed specifically for commercial teams, supporting planning, engagement and execution across the customer journey. It helps enhance precision, speed and business impact across commercial workflows.
Category: AI Agent Platforms
- Improve Workflow Precision And SpeedApply AI agents to commercial workflows to improve precision and speed and support greater business impact.
- Support Planning Engagement And ExecutionHelp commercial teams plan, engage and execute across the customer journey.
IQVIA Literature AI Platform
An agentic system built specifically for scientific literature review. It accelerates the process from search to synthesis while delivering rigorous, traceable outputs aligned with established quality standards.
- Find Relevant LiteratureThe platform supports scientific literature search and demonstrated 100% recall in search in the reported evaluation.
- Screen Documents PreciselyThe platform helps screen documents and demonstrated 93% or higher precision in document screening in the reported evaluation.
- Reduce Screening WorkloadBy automating parts of literature review, the platform reduced screening workload by more than 90% compared with manual review in the reported evaluation.
- Accelerate Literature SynthesisThe platform accelerates the process from literature search to synthesis, supporting a more streamlined scientific literature review.
- Produce Traceable OutputsThe platform provides rigorous, traceable literature-review outputs aligned with established quality standards.
IQVIA Privacy Analytics Platform
A platform that enables privacy-preserving use of data, including deployment within England's NHS Federated Data Platform.
- Enable Privacy-Preserving Data UseUse health data while protecting individual privacy.
- Deploy Within Federated Health Data InfrastructureDeployment within England's NHS Federated Data Platform supports use of the platform in a federated health data environment.
IQVIA SmartSolve RIM
IQVIA SmartSolve RIM is an AI-enabled regulatory information management platform that supports global regulatory approvals, compliance, and timely access to healthcare products.
- Manage Regulatory InformationCentralizes regulatory information management in a platform designed to support regulatory activities.
- Support Global ApprovalsSupports global regulatory approval processes, helping organizations work toward timely access to healthcare products.
- Strengthen Regulatory ComplianceSupports regulatory compliance as organizations manage requirements related to healthcare products.
IQVIA IRT Supply Automation Value Engine (SAVE)
A clinical trial supply program that uses real-time analytics and automation to optimize the supply of trial medicines to sites, reduce deliveries, and help prevent sites from running out of needed medicines.
- Monitor And Optimize SupplyReal-time analytics support monitoring and optimization of clinical trial medicine supply to sites.
- Reduce Drug Supply DeliveriesReducing deliveries helps optimize the movement of trial medicines to sites.
- Reduce Site Medicine StockoutsReducing stockouts helps trial sites avoid running out of medicines needed for clinical trials.
- Automate Clinical Supply ManagementAutomation supports the management of clinical trial medicine supply to sites.
AI-enabled clinical decision support tool for type 1 diabetes
An AI-enabled clinical decision support tool developed in collaboration with Breakthrough T1D to identify patients who may have misdiagnosed or misclassified type 1 diabetes.
- Identify Potentially Misdiagnosed PatientsHelps identify patients who may have misdiagnosed or misclassified type 1 diabetes.
- Reduce Screening BurdenThe tool reportedly reduced screening burden by 99.5%, requiring substantially fewer patient assessments.
IQVIA Emerging Biopharma Commercial Solutions
A dedicated IQVIA offering for emerging biopharma organizations, combining integrated data, expertise and purpose-built teams to support the journey from market prioritization through execution and from launch through growth. Its Asset Maximizer Commercial Success Framework provides an end-to-end commercialization roadmap to strengthen asset value, access, adoption and execution. The offering supports differentiation, stakeholder engagement, connected intelligence and operational excellence.
- Guide Asset CommercializationUse a structured roadmap to address commercialization challenges and support an asset’s progress from launch toward sustained commercial success.
- Coordinate Lifecycle ExecutionWork with dedicated teams across commercial phases to connect market prioritization, launch and growth activities, with support tailored to an asset’s journey.
- Differentiate Asset ValueBuild and communicate a distinct value proposition using scientific storytelling, brand messaging and coordinated communications to help an asset stand out.
- Advance Market AccessCoordinate evidence, pricing, reimbursement and stakeholder engagement strategies to support access and adoption across the commercialization journey.
- Uncover Commercial OpportunitiesConnect data, Healthcare-grade AI and analytics to identify opportunities, inform decisions and monitor performance throughout commercialization.
- Personalize Stakeholder EngagementCoordinate targeted, data-driven communications across channels to deliver relevant messages to stakeholders at the appropriate time.
- Scale Commercial OperationsApply disciplined execution, clear governance and operational rigor to support scalable commercialization and long-term growth.
- Build Launch CapabilitiesEstablish commercial infrastructure and coordinate workstreams, teams, governance, readiness and deployment to support launch execution.
Research & Development Solutions
IQVIA’s Research & Development solutions connect data, technology and analytics to optimize clinical trials, support faster decision-making and reduce risk. The offering spans early-phase and Phase IIb/III trials, patient- and site-centric tools and services, functional trial services, specialty and central laboratories, and R&D consulting. It also includes clinical development services for biotechnology companies delivered by specialized, dedicated teams, with therapeutically aligned support, patient and site services, laboratories and R&D consulting.
- Optimize Trials And Reduce RiskConnect trial data, technology and analytics to support optimized trials, faster decision-making and reduced risk.
- Advance Programs To MilestonesApply therapeutic expertise through dedicated teams to support clinical programs as they progress toward their next milestone.
- Establish Proof Of Concept FasterUse early clinical development strategies to track new-drug impact and establish proof of concept faster.
- Navigate Complex Later-Phase TrialsUse advanced AI and technology to address regulatory complexity and support enrollment strategies and patient engagement in Phase IIb/III trials.
- Improve Recruitment And Study ExecutionSupport patients and trial sites with tools and services intended to improve recruitment, engagement and study execution.
- Connect Trial DeliveryBring people, processes and technology together through agile, data-driven trial solutions for faster, smarter R&D delivery.
- Optimize R&D StrategyUse data, analytics, AI-powered technology and expertise to optimize R&D strategy, reduce risk and support compliance.
- Access Specialized Lab ExpertiseAccess specialty and central laboratory solutions with scientific rigor and expertise in biomarkers and antibody drug discovery.
Real World Evidence solutions
IQVIA generates and disseminates real-world evidence to address clinical, regulatory and commercial questions and support informed decisions. Its solutions include real-world and healthcare data, study design, evidence networks, health economics and value, and regulatory and safety support. IQVIA also draws on information from past trials, patient-reported outcomes and other sources to support research and evidence generation across the product lifecycle.
- Answer Critical Questions With EvidenceGenerate and disseminate evidence to address clinical, regulatory and commercial questions, supporting smarter decisions and stakeholder needs.
- Explore Data For Lifecycle InsightsExplore global real-world data and healthcare information to gain insights across the product lifecycle and support research.
- Design Studies With Emerging Evidence MethodsUse emerging data sources and evidence methods to support studies intended to demonstrate a product’s value and safety.
- Enrich Studies Through Evidence NetworksTap into evidence networks across oncology, neurology, immunology and other therapy areas to enrich studies.
- Demonstrate Product Value With Clearer EvidenceAccess clearer, more compelling support to demonstrate the value of a product.
- Address Regulatory And Safety NeedsAccess support for regulatory, safety and compliance needs across the product journey from concept to market.
Commercialization solutions
IQVIA's commercialization solutions combine data, analytics, technology and domain expertise to help organizations transform market strategy and execute precisely. The offering includes brand and portfolio strategy, launch management, commercial analytics, data and information management, HCP and patient engagement, omnichannel communications, pricing and market access, and optimization for established brands. Scalable resources and analytics powered by machine learning and artificial intelligence support commercial effectiveness across the product lifecycle.
- Improve Commercial DecisionsUse precise insights and fact-based decision-making to support commercial effectiveness and growth.
- Strengthen Product LaunchesApply launch strategies and insights to support launch performance and realize market potential.
- Shape Brand StrategySupport proactive brand growth and maximize brand impact across the product lifecycle.
- Use Quality DataApply quality data to inform business strategies, improve engagement decisions and identify opportunities.
- Apply AI-Powered AnalyticsUse analytics powered by machine learning and artificial intelligence to support commercial strategy and execution.
- Engage Healthcare ProfessionalsSupport precise healthcare professional engagement to strengthen brand share of voice and produce measurable results.
- Support Patient EngagementHelp improve adherence and disease understanding through patient engagement and support.
- Support Market AccessClarify how payers, providers and patients define value and support access for new and innovative products.
- Defend Brand Market ShareUse established-brand approaches to defend market share and maximize value across global markets.
- Personalize Cross-Channel CommunicationsCoordinate personalized communications across channels to support precise and efficient engagement.
Safety and regulatory compliance solutions
IQVIA combines technology, services and analytics-driven offerings to help organizations address changing stakeholder demands and cost constraints across safety, regulatory, quality and commercial compliance. The solutions include automated drug safety and pharmacovigilance, regulatory management, enterprise quality management, and processes for compliance with global engagement and transparency regulations and codes.
- Streamline Safety Work And Reduce CostsAutomation helps streamline end-to-end safety solutions while reducing the costs of safety operations.
- Automate And Standardize Regulatory ManagementAutomate and standardize regulatory management activities, including correspondence, commitments, registration and tracking.
- Manage Quality Across Your OrganizationManage quality across the organization with enterprise software that addresses manufacturing oversight and regulatory requirements.
- Manage Global Engagement And Transparency ComplianceWork with compliance experts to create, implement and manage efficient processes that support compliance with global engagement and transparency regulations and codes.
IQVIA Technologies
IQVIA Technologies combines data science, technology and analytics driven by artificial intelligence to support new efficiencies and business insights. The offering is designed to provide these capabilities without additional capital investment.
- Combine Data Science, Technology, And AIBring together data science, technology and artificial intelligence-driven analytics in one offering to support business needs.
- Support New Operational EfficienciesUse IQVIA Technologies' data-science, technology and analytics capabilities to support new efficiencies in business operations.
- Generate Business InsightsApply the offering's combined data science, technology and AI-driven analytics to support the generation of business insights.
- Access Capabilities Without Additional Capital InvestmentAccess data-science, technology and analytics capabilities intended to support efficiencies and business insights without additional capital investment.
IQVIA Virtual Research
IQVIA Virtual Research brings clinical trials and real-world studies to patients at home. The service is designed to boost recruitment and retention, speed timelines and improve data quality.
- Bring Research To PatientsPatients can participate in clinical trials and real-world studies at home.
- Boost Study RecruitmentVirtual research is designed to support recruitment by bringing trials and real-world studies to patients at home.
- Support Participant RetentionVirtual research is designed to support retention by bringing trials and real-world studies to patients at home.
- Speed Study TimelinesBringing trials and real-world studies to patients at home is intended to help speed timelines.
- Improve Data QualityIQVIA Virtual Research is intended to improve data quality in trials and real-world studies.
IQVIA Emerging Biopharma Analytics
IQVIA Emerging Biopharma Analytics supports commercial and launch planning with advanced analytics. A featured case study describes using patient claims data to generate actionable launch insights, helping an emerging biopharma company accelerate pre-launch decision-making and reduce costs.
- Turn Claims Data Into InsightsAnalysis of patient claims data helps transform complex information into actionable insights for launch planning.
- Accelerate Pre-Launch DecisionsInsights derived from patient claims data support faster pre-launch decision-making and commercial planning.
- Deploy Analytics In WeeksThe case study describes deploying advanced analytics in four weeks, demonstrating a rapid route from patient claims data to launch insights.
- Reduce Launch Planning CostsA featured case study reports a 75% cost reduction associated with deploying analytics to produce launch insights from patient claims data.
Sources
Methodology and sourcing behind the figures and links shown above.
Clinical development
Estimated using the clinical operations and development market as the closest match to end-to-end clinical trial execution and management across phases. Polaris Market Research reports a 2025 market size of USD 95.01 billion and a 7.1% CAGR for 2025–2034. Broader clinical trials market estimates provide corroboration.
- The global clinical operations and development market size was valued at USD 89.07 billion in 2024. The market is projected to grow from USD 95.01 billion in 2025 to USD 176.29 billion by 2034, exhibiting a CAGR of 7.1% during 2025–2034.
- Clinical Trials Market size was valued at USD 99.1 billion in 2026 and is projected to reach USD 198.62 billion by the end of 2036, registering around 7.2% CAGR.
Life sciences commercialization
No search result gives a direct market size or CAGR for life sciences commercialization. The $25B estimate is an approximate global sizing of commercial data, analytics, and execution services, using the reported $12B in outsourced life sciences IT spending as a relevant but partial proxy. The 8% growth estimate reflects the reported 6–7% pharmaceutical-sector CAGR, with additional demand from digital, analytics, and AI adoption. Both values are directional estimates, not directly reported segment figures.
Real-world evidence and HEOR
Estimated global 2025 market for the combined segment at approximately $5.0 billion. Published estimates place the RWE market at $4.15 billion for 2025 (MRFR) and RWE solutions at $2 billion for 2024 (Research and Markets), while HEOR services are estimated at $1.73 billion for 2025. Because HEOR services and RWE solutions overlap, these figures should not be added directly; the estimate accounts for that overlap. Growth potential is estimated at 15.8% CAGR, balancing the cited RWE forecasts of 16.5% and 17.2% with the HEOR services forecast of 13.45%.
- 2025 Market Size $4.15 Billion; CAGR (2025 - 2035) 17.2%.
- The Global Health Economics & Outcomes Research Service Market Size Was Estimated at USD 1.73 Billion in 2025; CAGR of around 13.45%.
- The global Real-World Evidence Solutions market is projected to reach USD 4.5 Billion by 2029 from USD 2 billion in 2024, at a CAGR of 16.5%.
Pharmacovigilance and regulatory compliance
The search results contain no relevant market-size or growth data. Estimate is based on internal knowledge of pharmacovigilance, regulatory affairs, and related life-sciences compliance software and services markets; the broad segment definition introduces substantial scope uncertainty. CAGR reflects continued demand for safety monitoring, regulatory compliance, and digital platforms.
Health data privacy
Estimated the segment at approximately USD 1.43 billion by applying healthcare’s reported 31.85% share of the USD 4.50 billion 2025 data privacy software market. The search results do not provide a CAGR specifically for health data privacy platforms, so the overall data privacy software market CAGR of 8.12% is used as a proxy. This is an approximate proxy because the specified segment is narrower than healthcare privacy software overall.
- IQVIA
- IQVIA Life Science Models
- Predictive Clinical Development
- IQVIA.ai
- IQVIA Field Force Agent
- IQVIA Global Market Insights Agent
- IQVIA Explorer
- IQVIA Commercial Agentic AI
- IQVIA Literature AI Platform
- IQVIA Privacy Analytics Platform
- IQVIA SmartSolve RIM
- IQVIA IRT Supply Automation Value Engine (SAVE)
- AI-enabled clinical decision support tool for type 1 diabetes
- IQVIA Emerging Biopharma Commercial Solutions
- Real World Evidence solutions
- Commercialization solutions
- Safety and regulatory compliance solutions
- IQVIA Technologies
- IQVIA Virtual Research
- IQVIA Emerging Biopharma Analytics
- The global clinical operations and development market size was valued at USD 89.07 billion in 2024. The market is projected to grow from USD 95.01 billion in 2025 to USD 176.29 billion by 2034, exhibiting a CAGR of 7.1% during 2025–2034.
- Clinical Trials Market size was valued at USD 99.1 billion in 2026 and is projected to reach USD 198.62 billion by the end of 2036, registering around 7.2% CAGR.
- The life sciences IT market is also expanding, with total spending around $40 billion, of which approximately $12 billion is outsourced.
- 2025 Market Size $4.15 Billion; CAGR (2025 - 2035) 17.2%.
- The Global Health Economics & Outcomes Research Service Market Size Was Estimated at USD 1.73 Billion in 2025; CAGR of around 13.45%.
- The global Real-World Evidence Solutions market is projected to reach USD 4.5 Billion by 2029 from USD 2 billion in 2024, at a CAGR of 16.5%.
- The data privacy software market was valued at USD 4.50 billion in 2025.
This is a public preview. Whoever claims it decides what it shows.
This profile was built from public information. Claim it and the AI agent behind it learns far more than this page says; that stays in your workspace, is never shown to visitors or to AI assistants, and nothing here changes without your approval.
Own this company? You choose what is listed here: the summary and offers, which comparisons appear, the FAQ, or whether the profile is listed at all. Unlisting takes one switch.
Built from public web sources. Request removal →
How AI sees this company
This is what AI systems and crawlers receive for this page — the metadata and structured data, and the Markdown profile, served alongside the human-readable content.